|
Market Closed -
NSE India S.E.
07:05:08 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 2,317.90 INR | -0.64% |
|
-0.02% | +13.89% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.64% | -0.02% | +5.36% | +2.60% | +13.89% | +19.65% | +205.39% | +329.44% | +170.93% | 6.84B | |
| -0.08% | -1.43% | -2.09% | +3.13% | +10.62% | +15.87% | +67.24% | +149.94% | +147.03% | 47.71B | |
| -3.21% | +1.37% | +11.17% | +4.68% | +37.44% | +51.19% | +124.26% | +158.04% | +168.55% | 40.3B | |
| -0.40% | -1.23% | +1.21% | +2.36% | -5.23% | -10.08% | +17.30% | +60.77% | +156.85% | 12.09B | |
| +1.11% | -1.34% | -0.56% | +7.80% | +22.49% | +13.27% | +72.07% | +109.40% | +203.40% | 11.68B | |
| +0.19% | +0.58% | 0.00% | +0.58% | +28.08% | +30.98% | +151.21% | +131.11% | +344.37% | 9.19B | |
| -0.39% | -0.92% | +9.71% | +7.33% | +30.56% | +20.49% | +39.85% | +42.01% | +130.04% | 7.57B | |
| -1.35% | +0.74% | +1.79% | -1.39% | +12.68% | +47.38% | -12.13% | -5.65% | -13.18% | 7.24B | |
| -5.36% | -6.36% | -5.03% | -7.55% | -34.05% | -38.04% | +19.49% | +30.20% | +13.16% | 5.42B | |
| -0.51% | -0.90% | +5.23% | +17.13% | +31.45% | +37.95% | +105.39% | +143.69% | +175.96% | 4.75B | |
| +2.78% | +2.75% | -1.32% | +8.96% | +26.41% | +41.88% | -21.31% | -20.43% | -59.38% | 4.09B | |
| -0.98% | -0.49% | -9.31% | +15.93% | +0.92% | -14.33% | +92.05% | +61.71% | - | 3.96B | |
| +3.04% | -2.40% | +1.33% | +19.73% | +30.43% | +27.50% | +707.84% | +315.62% | +139.76% | 3.2B | |
| 0.00% | -0.43% | +8.18% | +4.17% | -2.96% | -5.04% | +50.44% | +212.50% | +751.39% | 2.93B | |
| -7.71% | -10.74% | +10.41% | -54.65% | -27.44% | -3.76% | +191.87% | +200.71% | +1,672.06% | 2.85B | |
| +3.00% | +6.29% | +19.49% | -2.92% | -15.57% | -21.43% | +59.83% | +87.95% | +13.65% | 2.83B | |
| -0.53% | -2.84% | -7.15% | -9.66% | -3.95% | +7.57% | +61.41% | +13.32% | +70.55% | 2.63B | |
| +1.35% | +0.49% | -2.66% | -6.98% | +0.28% | -9.51% | +24.74% | - | - | 2.62B | |
| -4.15% | -5.09% | +2.08% | -10.50% | +9.54% | -44.61% | +91.11% | +52.03% | - | 2.45B | |
| +1.09% | +3.12% | +3.11% | +26.09% | +38.94% | +18.05% | +148.24% | +231.73% | +946.17% | 2.03B | |
| Average | -0.64% | -0.90% | +2.55% | +1.34% | +10.23% | +9.25% | +109.81% | +121.27% | +295.96% | 9.12B | |
| Weighted average by Cap. | -0.95% | -0.58% | +2.94% | +3.08% | +16.60% | +20.75% | +93.43% | +129.98% | +193.41% |
- Stock Market
- Stocks
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
